BioCentury | Aug 17, 2015
Strategy

Shifting MS spending

...on its 2015 list. For 2016 it reversed course by reinstating Rebif and removing Novartis' Extavia...
BioCentury | Aug 7, 2015
Top Story

CVS releases 2016 formulary

...119 excluded drugs. Multiple sclerosis (MS) drugs Plegridy peginterferon beta-1a from Biogen Inc. (NASDAQ:BIIB) and Extavia...
BioCentury | Nov 12, 2012
Company News

UnitedHealth Group sales and marketing update

...five drugs for which coupons will no longer be accepted are multiple sclerosis (MS) drugs Extavia...
BioCentury | Nov 1, 2010
Regulation

Biosimilar Fault Lines

...multiple sclerosis drug Betaferon from Bayer AG . Novartis markets its own branded version called Extavia...
BioCentury | Sep 27, 2010
Strategy

Marketing: Gilenya's uptake

...Avonex is given weekly via intramuscular injection, while Betaseron interferon beta-1b from Bayer AG and Extavia...
BioCentury | Jun 14, 2010
Regulation

Fingolimod: Test, then use

...injection. Avonex is delivered weekly via intramuscular injection. Betaseron interferon beta-1b from Bayer AG and Extavia...
BioCentury | Jun 7, 2010
Company News

Biogen Idec, Bayer, Merck KGaA, Novartis, Pfizer autoimmune news

...FDA in 2002 and had 2009 sales of €1.5 billion ($2.2 billion). Novartis and Bayer's Extavia...
BioCentury | Apr 22, 2010
Cover Story

Markers for interferon responsiveness in MS

...Bayer markets interferon beta-1b as Betaseron in the U.S. and as Betaferon in the EU. Extavia...
BioCentury | Feb 1, 2010
Strategy

57 flavors of experience

...U.S. sales force reorganization begun last year and by the marketing strategy for MS drug Extavia...
...with customers to improve care in ways that extend beyond drug therapy. For example, when Extavia...
...was to differentiate Novartis through patient and physician support (see BioCentury, Sept. 7, 2009). "While Extavia...
BioCentury | Jan 11, 2010
Finance

Post-Launch Report

...Pharyngitis and/or tonsillitis U.S. $7.3 (NASDAQ:MBRK) extended-release tablets secondary to Streptococcus pyogenes Novartis AG (NYSE:NVS; Extavia...
Items per page:
1 - 10 of 21